We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.30 | 4.58% | 6.85 | 6.50 | 7.20 | 6.95 | 6.65 | 6.65 | 1,561,355 | 11:25:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -6.72 | 41.12M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/1/2017 08:55 | It certainly is an eye watering placing and in hindsight it's now easy to see whay the company started doing so many presentations towards the end of last year. It's plainly disappointing that the CEO isn't taking a single share in the placing, which is almost unheard of. However it's worth noting that the non-exec Graeme Speirs is taking 7.5m, which is significant in anyone's book and I'm also glad to see Miton taking on 31.25m, so around 40% will be in firm hands. The market cap will rise to 50m with the new shares, so revenues are going to have to increase sharply to justify that valuation, so we'll have to see if the company can deliver. | daz | |
25/1/2017 08:38 | This is the low now been held down for placing shares im moping them up | toolsmoker | |
25/1/2017 08:36 | Agreed Chris. You don't raise £20m+ in this market unless your business is rock solid.Game on | trotterstrading | |
25/1/2017 08:31 | Well, whatever has gone before, the backing of decent institutional investors, gives us a good base to rapidly grow from... | chrisdgb | |
25/1/2017 08:22 | The director buys are already in the RNS | chimers | |
25/1/2017 08:20 | They needed the money to be able to stay in the game with the big lads . | chimers | |
25/1/2017 08:18 | QP. They don't really care about PI money.. that's clear from the measly allocation in the open offer.City Spivs knew this was coming and have walked the price down the get lower entry. It's a crooked system but it's all we've got. What I want to see now is meaningful director buys to shore up confidence. | trotterstrading | |
25/1/2017 08:11 | Good to know Timbo.Those who did participate have clearly seen/heard something they like. It's a given DARPA is going to scale up this year and next. If the US military go the same way with the rugged D3S then KMK will make hundreds of millions in revenue over the next 5 years | trotterstrading | |
25/1/2017 08:07 | Well, now at least you know why there is a presentation tonight. not because they are really interested to update pi's but because they want your money. ALL IMO. DYOR. QP | quepassa | |
25/1/2017 07:58 | I was offered the chance to participate in this one, but declined as it was there was little or no discount and it did not qualify for EIS tax relief, the latter being pretty much a prerequisite for me nowadays I have a small interest through Amphion, so I will go along to the Equity Development presentation this evening at Fladgate and hear the investment case. | timbo003 | |
25/1/2017 07:45 | Yes it's was obviously common knowledge in the market. But it done now and we have new II's investors and PI will have a (brief) period to load up at the same level | trotterstrading | |
25/1/2017 07:30 | Soak it up mmmmmmmmmmm gravy. | chimers | |
25/1/2017 07:24 | Take a while to settle. | chimers | |
25/1/2017 07:22 | Its not so much the placing as we all knew they had to have one. | chimers | |
25/1/2017 07:12 | Thats big of them eh!! | chimers | |
25/1/2017 07:11 | No discount . | chimers | |
25/1/2017 07:09 | Hardly. No discount and NEW BLUE CHIP ii'sCashed up and ready for global scale up! | trotterstrading | |
23/1/2017 15:24 | Think this needs finding to shore up balnce sheet once that is done then will start to rise Think this is the bottom we await news | toolsmoker | |
23/1/2017 14:26 | You just answered your own question. DO NOTHING. | chimers | |
23/1/2017 14:22 | I'm trying to work out if it's worth averaging down on this one or the downward spiral (in the share price) will continue.... It could be a cheap price - then again it could also be expensive! | bsharman3 | |
17/1/2017 14:10 | A reminder that if you would like to hear Arnab Basu, CEO, present on behalf of Kromek he will be appearing at our next investor forum on the evening of Wednesday 25th of January. Also appearing will be the management of Ergomed and Realm Therapeutics. To learn more about the forum and to register for free please follow this link: hxxps://www.eventbri Thanks, The Equity Development team | hannahh | |
13/1/2017 12:32 | Selling done?! Overhang clear? Let's see where this goes oversold IMO | trotterstrading | |
13/1/2017 11:45 | See you there Ali. Looking forward the CEO's responses to some awkward questions | trotterstrading | |
12/1/2017 20:54 | Remember guys, we've given them our capital to use in the business and they are fully accountable to shareholders . If they've lost so much shareholder value, they must be held accountable for the loss of shareholder value. Grassroots shareholder activism is increasingly important in sending messages to management and whilst the ED investor forum is not an AGM, it is nonetheless a good opportunity to ask direct, probing questions and to expect direct answers. The company's performance and responses at the investor presentation will no doubt subsequently be discussed here on these bulletin boards. ALL IMO. DYOR. QP | quepassa |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions